CD274 and neoplasm: Ligation of PD1 with PDL1 inhibits T cell cytotoxicity (21, 22) and the use of anti-PD1 perturbing this receptor/ligand interaction can unleash the suppressed cytotoxicity of T cells to kill the tumor cells (23).